News for Palatin Technologies, Inc. (PTNA.F)

Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of -100.00% and -182.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Companies Reporting Before The Bell • Analog Devices (NASDAQ:ADI) is projected to report quarterly earnings at $1.32 per share on revenue of ...

Mailing Address 4B CEDAR BROOK DRIVE CRANBURY NJ 08512 Business Address 4B CEDAR BROOK DRIVE CRANBURY NJ 08512 609-495-2200 CIK : 0000911216 (see all company ...

This morning 533 companies reached new 52-week highs. Intriguing Points: The largest company on a market cap basis to set a new 52-week high ...

Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor systems, today announced the filing of an international patent application under the Patent Cooperation Treaty (PCT) directed to the composition of PL9643 and a related family of melanocortin agonist peptides.